期刊文献+

CD44v6、ICAM-1与E-cadherin在子宫内膜异位症中的表达及意义 被引量:6

Expressions and significance of CD44V6,ICAM-1 and E-cadherin in endometriosis
原文传递
导出
摘要 目的:研究子宫内膜异位症(EM)患者在位和异位内膜粘附分子CD44拼构变异体6(CD44v6)、细胞间粘附分子-1(ICAM-1)和细胞钙粘附素E(E-cadherin)表达及其在EM发病机制中的作用。方法:采用S-P免疫组化染色法对30例子宫内膜异位症患者的异位内膜、在位内膜与30例正常子宫内膜进行CD44v6、ICAM-1和E-cadherin检测。结果:①异位内膜组CD44v6、ICAM-1表达明显升高,差异有统计学意义(P<0.05),E-cadherin表达明显降低,差异有统计学意义(P<0.05);②在位内膜组CD44v6、ICAM-1和E-cadherin表达明显降低,差异有统计学意义(P<0.05)。结论:CD44v6、ICAM-1、E-cadherin和子宫内膜异位症的发生发展密切相关。 Objective : To study the expressions of CD44v6, ICAM - 1 and E - cadherin in ectopic endometrium and eutopic endo- metrium of endometriosis and their roles in pathogenesis of endometriosis. Methods : The expression levels of CD44v6, ICAM - 1 and E - cadherin from ectopic endometrium and eutopic endometrium in 30 cases with endometriosis and normal endometrium from 30 cases without endometriosis were detected by immunohistochemical SP method. Results : The expression levels of CD44v6 and ICAM - 1 in ectopie endo- metrium group increased significantly ( P 〈 0. 05 ), the expression level of E - eadherin in eetopie endometrium group decreased significantly ( P 〈 0. 05 ) ; the expression levels of CD44v6, ICAM - 1 and E - eadherin in eutopie endometrium group decreased significantly ( P 〈 0. 05 ) Conclusion : CIM4v6, ICAM - 1 and E - eadherin are related to oncogenesis and development of endometriosis closely.
出处 《中国妇幼保健》 CAS 北大核心 2010年第15期2135-2137,共3页 Maternal and Child Health Care of China
基金 温州市科技局资助项目〔Y20080119〕
关键词 子宫内膜异位症 CD44V6 ICAM-1 E-CADHERIN Endometriosis CD44v6 ICAM - 1 E - cadherin
  • 相关文献

参考文献7

二级参考文献67

  • 1罗锦辉,唐建武.PDGF-B、PDGFR-α在小细胞肺癌中的不同表达[J].肿瘤,2004,24(5):476-477. 被引量:12
  • 2PARKIN D M,BRAY F,FERLAY J,et al.Global cancer statistics,2002[J].CA-Cancer J Clin,2005,55(2):74-108.
  • 3SCHNEIDER S,YOCHIM J,BRABENDER J,et al.Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer[J].Clin Cancer Res,2004,10(5):1588-1596.
  • 4MIYOSHI T,KONDO K,HINO N,et al.The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer[J].Clin Cancer Res,1997,3(8):1289-1297.
  • 5SHIJUBO N,UEDE T,KON S,et al.Vascular endothelial growth factor and osteopontin in stage 1 lung adenocarcinoma[J].Am J Respir Crit Care Med,1999,160:1269-1273.
  • 6BROWN L F,PAPADOPOULOS S A,BERSE B,et al.Osteopontin expression and distribution in human carcinomas[J].Am J Pathol,1994,145:610-623.
  • 7ZHANG J,TAKAHASHI K,TAKAHASHI F,et al.Differential osteopontin expression in lung cancer[J].Cancer Let,2001,171:215-222.
  • 8AGRAWAL D,CHEN T,IRBY R,et al.Osteopontin identified as lead marker of colon cancer progression,using pooled sample expression profiling[J].J Natl Cancer Inst,2002,94:513-521.
  • 9DENHARDT DT,GIACHELLI C M,RITTLING SR.Role of osteopontin in cellular signaling and toxicant injury[J].Annu Rev Pharmacol Toxicol,2001,41:723-749.
  • 10KATAGIRI Y U,SLEEMAN J,FUJII H,et al.CD44 variants but not CD44s cooperate with b1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycineaspartic acid,thereby stimulating cell motility and chemotaxis[J].Cancer Res,1999,59:219-226.

共引文献297

同被引文献49

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部